Related Experiment Videos

Role of the augmentation index in hypertension

Motohiro Shimizu1, Kazuomi Kario

  • 1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Therapeutic Advances in Cardiovascular Disease
|January 7, 2009
PubMed

Insights

Central blood pressure (BP) is clinically useful for cardiovascular risk. The augmentation index (AIx) measures wave reflection, but its clinical utility requires further study for improved cardiovascular disease management.

Area of Science:

  • Cardiovascular Physiology
  • Biomedical Engineering
  • Clinical Pharmacology

Background:

  • Central blood pressure (BP) is a key cardiovascular disease risk index.
  • Arterial pulse waveform analysis involves forward and backward pressure waves.
  • The augmentation index (AIx) quantifies wave reflection and its impact on central BP.

Purpose of the Study:

  • To review recent findings on the augmentation index (AIx).
  • To discuss the role of AIx in clinical practice.
  • To highlight the need for further research into AIx clinical utility.

Main Methods:

  • Literature review of studies on AIx.
  • Analysis of AIx in relation to age and cardiovascular risk.
  • Evaluation of antihypertensive drug effects on AIx.

Main Results:

  • AIx is influenced by the interaction of forward and reflected pressure waves.
  • Non-linear relationships between age and AIx have been observed.
  • Antihypertensive medications demonstrate varied effects on AIx.

Conclusions:

  • The clinical usefulness of AIx is not yet fully established.
  • Further research is necessary to clarify the role of AIx in clinical practice.
  • AIx may potentially influence future cardiovascular disease management strategies.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...